Home  ■  Participation  ■  Assessments  ■  Epitopes  ■  Protocols  ■  Techniques  ■  Links

Participation

New participant

Click on New participant if you wish to apply for enrolment for the first time. When accepted by NordiQC, a participant number and password is e-mailed within a few days.

Before filling out the form, please read Subscription and Assessment method.
Do NOT use this form if you are already enrolled. E-mail us, if you have problems with log-in etc.

The buttons below are for registered participants only. Password protected.
Note: The password only works with www.nordiqc.org (not with www.nordiqc.com)

Participant data

The technical problems have been solved by 6th March
Click on Participant data to check and modify participant names etc.
Include up to four contact persons (at least three is recommended).
The participants are exclusively responsible for the correctness of their data.

Protocol form 1

General module
Protocol form 1 (General module) is open for submission of changed protocols.

 

Protocol form 2

Breast cancer module

Protocol form 2 (Breast cancer module) is CLOSED until run B9 opens by 01 April 2010.

   

2010 modules
General module

Events

Run 28

Run 29

Run 30

Epitopes to be detected
(click on underlined markers for description)

 BCL2, BCL6, BSAP, CD99, EMA, WT1 CA125, CD4, CD79a, CK19, SYP CD34, CK-PAN, IgM, MLH1, VIM

NordiQC: Advertising the new run

01 January1)

01 April

01 September

Participant: Deadline for protocol submission

13 January2)

13 April

13 September

NordiQC: Circulation of unstained slides

21 January3)

21 April

21 September

Participant: Deadline for return of stained slides

05 February

05 May

06 October

NordiQC: Assessment date and venue

13-14 February (Finland)

18-19 May (Reykjavik)

21-22 October (Aalborg)
NordiQC: Upload of general results, submission of individual results 07 April 07 July 07 December

1) All dates indicated are approximate and may be changed by NordiQC if needed. Changes will appear on this site.
2) Also deadline for enrolment.  4) Also billing.

Abbreviations: BSAP: B-cell specific activator protein, PAX-5; CA125: Cancer antigen 125; CK: Cytokeratin; EMA: Epithelial membrane antigen; SYP: Synaptophysin; VIM: Vimentin; WT1: Wilms' tumor-1.


Breast cancer module

Events

Run B9

Run B10

Epitopes to be detected

(click on underlined markers for description)

 - PR, HER-2 IHC*,
HER-2 CISH/SISH		 ER, HER-2 IHC*,
HER-2 CISH/SISH

NordiQC: Advertising the new run

-

01 April

01 September

Participant: Deadline for protocol submission

 -

15 April

15 September

NordiQC: Circulation of unstained slides

-

23 April

23 September

Participant: Deadline for return of stained slides

 -

10 May

10 October

NordiQC: Assessment date and venue

-

Ca. 5-6 June (Aalborg)

Ca. 5-6 November (Aalborg)
NordiQC: Upload of general results, submission of individual results - 07 July 07 December

* Labs not performing HER-2 IHC may substitute with ER in run B9 and PR in run B10.

Abbreviations: CISH: Chromogene in situ hybridisation; ER: Estrogen receptor; IHC: Immunohistochemistry; PR: Progesterone receptor.SISH: Silver in situ hybridisation.

 

Markers in previous years

 
MV/AS

ADM

Last update 07-03-2010